Aids-related malignancies (Q22251046)

Dimensions Publication ID

Dimensions

6 February 2023

Chris Boshoff

1

Chris

Boshoff

1 reference

Dimensions Publication ID

Dimensions

1009496899

Genetic Studies of the Relationship of Tumour–Host Cells: Detection of an Allelic Difference at a Single Gene Locus in a Small Fraction of a Large Tumour-Cell Population

6 February 2023

language of work or name

English

0 references

publication date

1 May 2002

0 references

published in

Nature Reviews Cancer

0 references

volume

2

0 references

issue

5

0 references

page(s)

373-382

0 references

cites work

1 reference

Association of Cancer With AIDS-Related Immunosuppression in Adults

31 March 2020

1 reference

Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation

31 March 2020

1 reference

Cancer incidence in New York State acquired immunodeficiency syndrome patients.

31 March 2020

1 reference

31 March 2020

1 reference

Idiopathisches multiples Pigmentsarkom der Haut

31 March 2020

1 reference

Kaposi's sarcoma in the Bantu of Mozambique

31 March 2020

1 reference

Kaposi's sarcoma in recipients of renal transplants

31 March 2020

1 reference

Kaposi's sarcoma in transplant recipients

31 March 2020

1 reference

Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia

31 March 2020

1 reference

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

31 March 2020

1 reference

Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.

31 March 2020

1 reference

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

31 March 2020

1 reference

The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission

31 March 2020

1 reference

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

31 March 2020

1 reference

The microenvironment of the tumour-host interface

31 March 2020

1 reference

Inflammatory cells and cancer: think different!

31 March 2020

1 reference

Putting tumours in context

31 March 2020

1 reference

Peritoneal macrophage response to leukemia L1210 in syngeneic mice

31 March 2020

1 reference

The enigmas of Kaposi's sarcoma

31 March 2020

1 reference

Monoclonal Origin of Multicentric Kaposi's Sarcoma Lesions

31 March 2020

1 reference

Evidence for multiclonality in multicentric Kaposi's sarcoma

31 March 2020

1 reference

Cellular and molecular features of HIV-associated Kaposi's sarcoma

31 March 2020

1 reference

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

31 March 2020

1 reference

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

31 March 2020

1 reference

Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.

31 March 2020

1 reference

AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6

31 March 2020

1 reference

AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

31 March 2020

1 reference

Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma

31 March 2020

1 reference

Angiogenic properties of human immunodeficiency virus type 1 Tat protein

31 March 2020

1 reference

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

31 March 2020

1 reference

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

31 March 2020

1 reference

Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma

31 March 2020

2 references

31 March 2020

7 January 2021

Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV).

1 reference

Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma

31 March 2020

1 reference

The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells

31 March 2020

1 reference

The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element

31 March 2020

1 reference

Monoclonality or Oligoclonality of Human Herpesvirus 8 Terminal Repeat Sequences in Kaposi's Sarcoma and Other Diseases

31 March 2020

1 reference

Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa

31 March 2020

1 reference

Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel.

31 March 2020

1 reference

Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents

31 March 2020

1 reference

Antibodies against human herpesvirus 8 in black South African patients with cancer.

31 March 2020

1 reference

Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates

31 March 2020

1 reference

Mucosal shedding of human herpesvirus 8 in men.

31 March 2020

1 reference

Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985.

31 March 2020

1 reference

Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa

31 March 2020

1 reference

Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population

31 March 2020

1 reference

Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73.

31 March 2020

1 reference

Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda

31 March 2020

1 reference

Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone

31 March 2020

1 reference

Epstein-Barr virus: exploiting the immune system

31 March 2020

1 reference

Epstein-Barr virus strategy in normal and neoplastic B cells

31 March 2020

1 reference

Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors

31 March 2020

1 reference

Cellular origin of human B-cell lymphomas.

31 March 2020

1 reference

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

31 March 2020

1 reference

Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation

31 March 2020

1 reference

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

31 March 2020

1 reference

Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome

31 March 2020

1 reference

INFECTIOUS PAPILLOMATOSIS OF RABBITS : WITH A NOTE ON THE HISTOPATHOLOGY

31 March 2020

2 references

31 March 2020

7 January 2021

THE CARCINOGENIC EFFECT OF A VIRUS UPON TARRED SKIN.

1 reference

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

31 March 2020

1 reference

Skin cancer and immunosuppression

31 March 2020

1 reference

Chronic antigenic stimulation, herpesvirus infection, and cancer in transplant recipients

31 March 2020

1 reference

ASSOCIATION BETWEEN ANORECTAL DYSPLASIA, HUMAN PAPILLOMAVIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HOMOSEXUAL MEN

31 March 2020

1 reference

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

31 March 2020

1 reference

Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda

31 March 2020

1 reference

Genital human papillomavirus infection and associated penile intraepithelial neoplasia in males infected with the human immunodeficiency virus

31 March 2020

1 reference

Human immunodeficiency virus infection is a major risk factor for detection of human papillomavirus DNA in esophageal brushings

31 March 2020

1 reference

Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.

31 March 2020

1 reference

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women

31 March 2020

1 reference

Human papillomavirus infection in women infected with the human immunodeficiency virus

31 March 2020

1 reference

Biology of human papillomaviruses

31 March 2020

1 reference

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

31 March 2020

1 reference

Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic

31 March 2020

1 reference

The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma

31 March 2020

1 reference

Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery

31 March 2020

1 reference

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

31 March 2020

1 reference

Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

31 March 2020

1 reference

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

31 March 2020

1 reference

Resolution of recalcitrant hand warts in an HIV-infected patient treated with potent antiretroviral therapy

31 March 2020

1 reference

Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.

31 March 2020

1 reference

Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders

31 March 2020

1 reference

Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy

31 March 2020

1 reference

Lymphatic endothelium: a new frontier of metastasis research

31 March 2020

1 reference

Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

31 March 2020

1 reference

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

31 March 2020

1 reference

Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex

31 March 2020

1 reference

Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus

31 March 2020

1 reference

Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.

31 March 2020

1 reference

Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication

31 March 2020

1 reference

Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus

31 March 2020

1 reference

Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active an

31 March 2020

1 reference

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

31 March 2020

1 reference

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

31 March 2020

1 reference

Highly active antiretroviral therapy inhibits cytokine production in HIV-uninfected subjects

31 March 2020

1 reference

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

31 March 2020

1 reference

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma

31 March 2020

1 reference

Developmental biology. One cell, two fates.

31 March 2020

1 reference

Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors

31 March 2020

1 reference

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

31 March 2020

1 reference

VEGFR-3 in adult angiogenesis.

31 March 2020

1 reference

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium

31 March 2020

1 reference

Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells

31 March 2020

1 reference

Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53

31 March 2020

1 reference

Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells

31 March 2020

1 reference

7 January 2021

The molecular biology of cervical cancer

1 reference

7 January 2021